Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.00

+0.6%

11:40 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (3478)	4/20/2001 11:36:58 AM
From: XenaLives	Read Replies (3) of 52153

I understand your concern Peter, but I think the chance of approval is more than 50/50. The Lupus Dr's basically said it isn't a great drug, but it's all they have right now so they want approval. Even a lowering of steroids without additional efficacy would be an improvement for these patients so I think the FDA will probably go for it. In addition, I think the FDA wants to take DHEA off of over the counter, they have their own motivation for approval. I know some local health stores won't carry it for ethical reasons and my own physician said I should try it, but to be careful of the dosage. I don't think I would use it without my DR's ok. Still, from the painful lessons I've learned lately, I will probably sell part around $4.50 and let the profit ride. Maybe move into ARDM? Been watching it for a while.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next